200 related articles for article (PubMed ID: 34187438)
1. Enrolling a rural community pharmacy as a Vaccines for Children provider to increase HPV vaccination: a feasibility study.
Daniel CL; Lawson F; Vickers M; Green C; Wright A; Coyne-Beasley T; Lee HY; Turberville S
BMC Public Health; 2021 Jun; 21(1):1266. PubMed ID: 34187438
[TBL] [Abstract][Full Text] [Related]
2. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states.
Calo WA; Shah PD; Gilkey MB; Vanderpool RC; Barden S; Doucette WR; Brewer NT
Hum Vaccin Immunother; 2019; 15(7-8):1831-1838. PubMed ID: 30945968
[TBL] [Abstract][Full Text] [Related]
3. Improving HPV vaccination using implementation strategies in community pharmacies: Pilot study protocol.
Teeter BS; Mosley C; Thomas JL; Martin B; Jones D; Romero JR; Curran GM
Res Social Adm Pharm; 2020 Mar; 16(3):336-341. PubMed ID: 31174950
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers.
Boyd ED; Phillips JM; Schoenberger YM; Simpson T
Vaccine; 2018 Jun; 36(28):4126-4133. PubMed ID: 29793895
[TBL] [Abstract][Full Text] [Related]
5. The feasibility and acceptability of a pilot randomized controlled trial testing pharmacy-based HPV vaccine completion.
Koskan A; Zittel ME; Lee C; Sanchez O; Alvarez L; Helitzer DL
Res Social Adm Pharm; 2022 Jun; 18(6):3038-3045. PubMed ID: 34389257
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States.
Islam JY; Gruber JF; Kepka D; Kunwar M; Smith SB; Rothholz MC; Brewer NT; Smith JS
Hum Vaccin Immunother; 2019; 15(7-8):1839-1850. PubMed ID: 30550369
[TBL] [Abstract][Full Text] [Related]
7. Rural Caregivers' Willingness for Community Pharmacists to Administer the HPV Vaccine to Their Age-Eligible Children.
Koskan AM; Dominick LN; Helitzer DL
J Cancer Educ; 2021 Feb; 36(1):189-198. PubMed ID: 31493172
[TBL] [Abstract][Full Text] [Related]
8. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ
Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346
[TBL] [Abstract][Full Text] [Related]
9. Clinic-level differences in human papillomavirus vaccination rates among rural and urban Oregon primary care clinics.
Hatch BA; Valenzuela S; Darden PM; Fagnan LJ; Dickinson C; Marino M; Robison SG; Larsen R; Carney PA
J Rural Health; 2023 Mar; 39(2):499-507. PubMed ID: 36396353
[TBL] [Abstract][Full Text] [Related]
10. Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series.
Kajtezovic S; Morgan JR; Fiascone S; Brandt HM; Perkins RB
Hum Vaccin Immunother; 2023 Dec; 19(1):2175541. PubMed ID: 36798049
[TBL] [Abstract][Full Text] [Related]
11. Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates.
Teeter BS; Jensen CR; Thomas JL; Martin BC; McElfish PA; Mosley CL; Curran GM
Explor Res Clin Soc Pharm; 2021 Jun; 2():. PubMed ID: 35187525
[TBL] [Abstract][Full Text] [Related]
12. Rural-Urban Disparities in HPV Vaccination Coverage Among Adolescents in the Central Part of the State of Illinois, USA.
Adjei Boakye E; Fedorovich Y; White M; Vohra S; Volle M; Osazuwa-Peters N; Gerend MA
J Community Health; 2023 Feb; 48(1):24-29. PubMed ID: 36066667
[TBL] [Abstract][Full Text] [Related]
13. Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties.
White AA; Neelon B; Martin RH; Cartmell KB; Korte JE; Roberts JR; Williams EM
Vaccine; 2022 Feb; 40(9):1352-1360. PubMed ID: 35101264
[TBL] [Abstract][Full Text] [Related]
14. Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data.
Kepka D; Spigarelli MG; Warner EL; Yoneoka Y; McConnell N; Balch A
Papillomavirus Res; 2016 Dec; 2():128-132. PubMed ID: 27540595
[TBL] [Abstract][Full Text] [Related]
15. A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.
Gowda C; Dong S; Potter RC; Dombkowski KJ; Dempsey AF
J Adolesc Health; 2013 Oct; 53(4):498-505. PubMed ID: 24054080
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
17. Early Outcomes of a Multilevel Human Papillomavirus Vaccination Pilot Intervention in Federally Qualified Health Centers.
Fisher-Borne M; Preiss AJ; Black M; Roberts K; Saslow D
Acad Pediatr; 2018 Mar; 18(2S):S79-S84. PubMed ID: 29502642
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns.
Koskan A; Vizcaino M; Brennhofer SA; Lee CD; Roberto AJ
Hum Vaccin Immunother; 2021 Sep; 17(9):3090-3095. PubMed ID: 33886423
[TBL] [Abstract][Full Text] [Related]
19. Policy opportunities to increase HPV vaccination in rural communities.
Vanderpool RC; Stradtman LR; Brandt HM
Hum Vaccin Immunother; 2019; 15(7-8):1527-1532. PubMed ID: 30608894
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.
Lai D; Ding Q; Bodson J; Warner EL; Kepka D
Public Health Nurs; 2016 Jul; 33(4):283-94. PubMed ID: 26331614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
